196 related articles for article (PubMed ID: 32536221)
1. Proteogenomic biomarkers in colorectal cancers: clinical applications.
Binetti M; Lauro A; Vaccari S; Cervellera M; Tonini V
Expert Rev Proteomics; 2020 May; 17(5):355-363. PubMed ID: 32536221
[TBL] [Abstract][Full Text] [Related]
2. Advances in prognostic markers for colorectal cancer
Duan L; Yang W; Wang X; Zhou W; Zhang Y; Liu J; Zhang H; Zhao Q; Hong L; Fan D
Expert Rev Mol Diagn; 2019 Apr; 19(4):313-324. PubMed ID: 30907673
[TBL] [Abstract][Full Text] [Related]
3. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
Das V; Kalita J; Pal M
Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
[TBL] [Abstract][Full Text] [Related]
4. Proteomics for early detection of colorectal cancer: recent updates.
Alnabulsi A; Murray GI
Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727
[TBL] [Abstract][Full Text] [Related]
5. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
[TBL] [Abstract][Full Text] [Related]
6. New trends in molecular and cellular biomarker discovery for colorectal cancer.
Aghagolzadeh P; Radpour R
World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
[TBL] [Abstract][Full Text] [Related]
7. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic markers in colorectal cancer screening: recent advances.
Singh MP; Rai S; Suyal S; Singh SK; Singh NK; Agarwal A; Srivastava S
Expert Rev Mol Diagn; 2017 Jul; 17(7):665-685. PubMed ID: 28562109
[TBL] [Abstract][Full Text] [Related]
9. Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).
Nikolouzakis TK; Vassilopoulou L; Fragkiadaki P; Mariolis Sapsakos T; Papadakis GZ; Spandidos DA; Tsatsakis AM; Tsiaoussis J
Oncol Rep; 2018 Jun; 39(6):2455-2472. PubMed ID: 29565457
[TBL] [Abstract][Full Text] [Related]
10. Methods and biomarkers for early detection, prediction, and diagnosis of colorectal cancer.
Zhang Y; Wang Y; Zhang B; Li P; Zhao Y
Biomed Pharmacother; 2023 Jul; 163():114786. PubMed ID: 37119736
[TBL] [Abstract][Full Text] [Related]
11. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update.
Molnár B; Galamb O; Kalmár A; Barták BK; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Dank M
Expert Rev Mol Diagn; 2019 Jun; 19(6):477-498. PubMed ID: 31046485
[No Abstract] [Full Text] [Related]
12. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Ma H; Chen G; Guo M
Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
[TBL] [Abstract][Full Text] [Related]
13. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
[TBL] [Abstract][Full Text] [Related]
14. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer: Genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials.
Housini M; Dariya B; Ahmed N; Stevens A; Fiadjoe H; Nagaraju GP; Basha R
Gene; 2024 Jan; 892():147857. PubMed ID: 37783294
[TBL] [Abstract][Full Text] [Related]
16. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
Heiss JA; Brenner H
Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
[TBL] [Abstract][Full Text] [Related]
17.
Xiao YS; Tong HZ; Yuan XH; Xiong CH; Xu XY; Zeng YF
Exp Biol Med (Maywood); 2020 Aug; 245(14):1233-1241. PubMed ID: 32486849
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
[TBL] [Abstract][Full Text] [Related]
19. Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer.
Alves Dos Santos K; Clemente Dos Santos IC; Santos Silva C; Gomes Ribeiro H; de Farias Domingos I; Nogueira Silbiger V
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396209
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
